Clinical Trial

Use of Virtual Reality in Pain Management in Pediatric Oncology

Study acronym: DOREVI
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 13, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
DOREVI is a monocentric randomized controlled study that will evaluate the efficacy of virtual reality helmets for pain prevention during invasive care on 78 oncologic pediatric patients. Two groups of children (between 6 and 11 and between 12 and 18 years old) will be randomized to use helmet plus standard care or standard care alone during invasive procedures (central venous catheter puncture, lumbar puncture, or bone marrow aspiration). The pain intensity will be evaluated using a visual analogic scale during three invasive procedures, and results will be compared between the patients with or without virtual reality.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-10-19; most recent amendment 2026-03-11.
Status change: Not Yet Recruiting → Recruiting 2023-09-28
Trial Details
NCT Number NCT05592132
Lead Sponsor Centre Hospitalier Universitaire de la Réunion
Conditions Pediatric Tumor
Enrollment 74 participants
Start Date 2023-01-17
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2026-03-13